ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate0.130.131.080
Low Estimate-0.050.010.68-1.16
High Estimate0.370.351.911.14
Year Ago EPS-0.28-0.440.911.08
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate30.84M34.47M144.05M153.98M
Low Estimate25.6M32.66M135.6M119.4M
High Estimate37.25M39.13M163.27M178.94M
Year Ago Sales8.96M7.51M102.81M144.05M
Sales Growth (year/est)244.20%358.90%40.10%6.90%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.38-0.482.130.19
EPS Actual-0.28-0.441.860.59
Difference0.10.04-0.270.4
Surprise %26.30%8.30%-12.70%210.50%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate0.130.131.080
7 Days Ago0.130.131.080
30 Days Ago0.090.080.94-0.09
60 Days Ago0.090.080.94-0.09
90 Days Ago-0.48-0.55-1.46-1.6
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesENTAIndustrySectorS&P 500
Current Qtr.146.40%N/AN/A0.42
Next Qtr.129.50%N/AN/A0.39
Current Year18.70%N/AN/A0.20
Next Year-100.00%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)-28.34%N/AN/AN/A